Bitte aktiviere Javascript und schalte etwaige Werbeblocker ab

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Nagarro releases audited financial results for 2022, announces share buyback: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png

EQS-News: Nagarro releases audited financial results for 2022, announces share buyback

EQS-News: Nagarro releases audited financial results for 2022, announces share buyback

0

EQS-Adhoc: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 30 million euros: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png

EQS-Adhoc: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 30 million euros

EQS-Adhoc: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 30 million euros

0

EQS-News: AUTO1 Group SE: AUTO1 Group publishes 2022 ESG Report:

EQS-News: AUTO1 Group SE: AUTO1 Group publishes 2022 ESG Report

EQS-News: AUTO1 Group SE: AUTO1 Group publishes 2022 ESG Report

0

EQS-News: SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png

EQS-News: SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.

EQS-News: SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.

0

EQS-News: MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023

EQS-News: MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023

0

EQS-News: AUTO1 Group SE: Launch of the AUTO1 Group Price Index shows used car price stabilization after record decline:

EQS-News: AUTO1 Group SE: Launch of the AUTO1 Group Price Index shows used car price stabilization after record decline

EQS-News: AUTO1 Group SE: Launch of the AUTO1 Group Price Index shows used car price stabilization after record decline

0

EQS-News: CANCOM: Financial year 2022 ends with record revenue in the fourth quarter. Dividend proposal of €1.00 per share and forecast 2023 published.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png

EQS-News: CANCOM: Financial year 2022 ends with record revenue in the fourth quarter. Dividend proposal of €1.00 per share and forecast 2023 published.

EQS-News: CANCOM: Financial year 2022 ends with record revenue in the fourth quarter. Dividend proposal of €1.00 per share and forecast 2023 published.

0

EQS-News: SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png

EQS-News: SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.

EQS-News: SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.

0

EQS-Adhoc: SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png

EQS-Adhoc: SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.

EQS-Adhoc: SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.

0

EQS-Adhoc: 1&1 with successful fiscal year 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png

EQS-Adhoc: 1&1 with successful fiscal year 2022

EQS-Adhoc: 1&1 with successful fiscal year 2022

0

EQS-News: MorphoSys AG: Repurchase of portion of outstanding convertible bonds due 2025 (ISIN DE000A3H2XW6)

EQS-News: MorphoSys AG: Repurchase of portion of outstanding convertible bonds due 2025 (ISIN DE000A3H2XW6)

0

EQS-News: GRENKE AG: S&P lowered ratings for GRENKE AG to “BBB/A-2” – New outlook is “stable”: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg

EQS-News: GRENKE AG: S&P lowered ratings for GRENKE AG to “BBB/A-2” – New outlook is “stable”

EQS-News: GRENKE AG: S&P lowered ratings for GRENKE AG to “BBB/A-2” – New outlook is “stable”

0

EQS-News: MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)

EQS-News: MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)

0

EQS-News: Krones AG: Krones to increase dividend for 2022 by 25% to €1.75 per share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png

EQS-News: Krones AG: Krones to increase dividend for 2022 by 25% to €1.75 per share

EQS-News: Krones AG: Krones to increase dividend for 2022 by 25% to €1.75 per share

0

EQS-News: PATRIZIA Annual Report 2022: Solid operating performance, successful transformation and fifth dividend increase in a row: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24117/375px-Logo_Patrizia_Immobilien_AG.svg.png

EQS-News: PATRIZIA Annual Report 2022: Solid operating performance, successful transformation and fifth dividend increase in a row

EQS-News: PATRIZIA Annual Report 2022: Solid operating performance, successful transformation and fifth dividend increase in a row

0

EQS-News: PATRIZIA SE: PATRIZIA’s European Infrastructure Fund II surpasses EUR 800 million in committed investments with double fibre deal in Spain : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24117/375px-Logo_Patrizia_Immobilien_AG.svg.png

EQS-News: PATRIZIA SE: PATRIZIA’s European Infrastructure Fund II surpasses EUR 800 million in committed investments with double fibre deal in Spain

EQS-News: PATRIZIA SE: PATRIZIA’s European Infrastructure Fund II surpasses EUR 800 million in committed investments with double fibre deal in Spain

0

EQS-News: GRENKE presents its Annual Report 2022 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg

EQS-News: GRENKE presents its Annual Report 2022

EQS-News: GRENKE presents its Annual Report 2022

0

EQS-News: MorphoSys AG Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

EQS-News: MorphoSys AG Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

0

EQS-News: SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png

EQS-News: SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023

EQS-News: SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023

0

EQS-News: SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png

EQS-News: SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.

EQS-News: SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.

0

EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png

EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO

EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO

0

EQS-News: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer

EQS-News: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer

0

EQS-News: 1&1 AG: Deutsche Telekom loses in Court: 1&1 builds Europe's most advanced 5G network: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png

EQS-News: 1&1 AG: Deutsche Telekom loses in Court: 1&1 builds Europe's most advanced 5G network

EQS-News: 1&1 AG: Deutsche Telekom loses in Court: 1&1 builds Europe's most advanced 5G network

0

EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023

EQS-News: Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023

0

EQS-News: Nagarro targets change in auditors and announces Capital Markets Day: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png

EQS-News: Nagarro targets change in auditors and announces Capital Markets Day

EQS-News: Nagarro targets change in auditors and announces Capital Markets Day

0